The fourth surefire stock to buy right now with the S&P 500 ending March 13 in correction territory is the cheapest " ...

J&J has demonstrated a willingness to invest aggressively in internal drug development ... territory is auto parts supplier AutoZone (NYSE: AZO). The trend is most definitely AutoZone's friend.

Social media users and medical specialists have been raising awareness of a rare condition that stops people from burping, ...

([content-module:CompanyOverview, NYSE:AZO) Investors looking to get into Autozone (NYSE:AZO) on a deep pullback may have a long time to wait. This must-have buy-and-hold company’s FQ2 2025 ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors ...

What's really helped Johnson & Johnson is its decisive shift toward novel-drug development. Even though brand-name therapies have a finite period of sales exclusivity, they possess high margins ...

The company’s Cardiometabolic segment is driven by incretin medications and contributes majorly to the company’s growth. Full-year 2024 overall revenue for the company surged 32% year-over ...

Drug screening is the process by which potential drugs are identified and optimized before selection of a candidate drug to progress to clinical trials. It can involve screening large libraries of ...

However, there was insufficient evidence to say the drug was totally ineffective in ... Lymph Node Transfer Reduces Arm Swelling After Breast Cancer Surgery Mar. 18, 2025 — A study has shown ...

A 28-year-old woman developed allergic contact dermatitis within 6 to 24 hours exclusively after using carmine-containing eyeshadows and lipsticks. She had both a positive patch test result and a ...